Skip to content

The clinical efficacy of Dinuoan? dienogest in the treatment of endometrioma

The clinical efficacy of Dinuoan? dienogest in the treatment of endometrioma

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062743
Enrollment
Unknown
Registered
2022-08-17
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

experimental group:Dinuoan? dienogest
control group :Visanne? dienogest

Sponsors

Department of Gynecology and Obstetrics Hospital Affiliated to Zhejiang University Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Premenopausal women over 18 years of age with regular menstrual cycles; 2. diagnosed as endometrioma by B ultrasound or clinical examination; 3. cyst diameter = 3 cm; 5. Willing to participate in clinical trials and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. pregnancy, lactation and amenorrhea; 2. Recent need for fertility; 3. undiagnosed abnormal vaginal bleeding; 4. There is a clear indication for surgical treatment; 5. Any study involving contraindications; 6. other conditions considered unsuitable for participation by researchers.

Design outcomes

Primary

MeasureTime frame
Ovarian cyst size;

Secondary

MeasureTime frame
pain score;quality of life;CGI;

Countries

China

Contacts

Public ContactXinmei Zhang
zxm20130729@163.com+86 18957110072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026